Human adult bone marrow-derived stem cells decrease severity of lipopolysaccharide-induced acute respiratory distress syndrome in sheep

Stem Cell Research and Therapy

Volumn 5, Issue 2, 2014, Pages

  Rojas, Mauricio ^a,b   Cárdenes, Nayra ^a,b   Kocyildirim, Ergin ^b   Tedrow, John R ^a,b   Cáceres, Eder ^b   Deans, Robert ^c   Ting, Anthony ^c   Bermúdez, Christian ^b  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c ATHERSYS INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBON DIOXIDE; SODIUM CHLORIDE; LIPOPOLYSACCHARIDE;

ADULT; ADULT STEM CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD OXYGENATION; CONTROLLED STUDY; DISEASE SEVERITY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HYPOXEMIA; LUNG EDEMA; LUNG HEMODYNAMICS; LUNG PRESSURE; NONHUMAN; PNEUMONIA; PRIORITY JOURNAL; RESPIRATORY DISTRESS; SHEEP; THERAPY EFFECT; ANIMAL; BONE MARROW CELL; BONE MARROW TRANSPLANTATION; CHEMICALLY INDUCED; CYTOLOGY; DISEASE MODEL; PROCEDURES; RESPIRATORY DISTRESS SYNDROME, ADULT; STEM CELL TRANSPLANTATION;

ADULT STEM CELLS; ANIMALS; BONE MARROW CELLS; BONE MARROW TRANSPLANTATION; DISEASE MODELS, ANIMAL; HUMANS; LIPOPOLYSACCHARIDES; RESPIRATORY DISTRESS SYNDROME, ADULT; SHEEP; STEM CELL TRANSPLANTATION;

EID: 84899703981     PISSN: None     EISSN: 17576512     Source Type: Journal    
DOI: 10.1186/scrt430     Document Type: Article

References (55)

1. Schraufnagel DE, Breathing in America: Diseases, Progress, and Hope New York: American Thoracic Society 2010
2. Acute respiratory distress syndrome: the Berlin Definition. Ranieri VM, Rubenfeld GD, Thompson BT, Ferguson ND, Caldwell E, Fan E, Camporota L, Slutsky AS, JAMA 2012 307 2526 2533 22797452
3. The Berlin definition of ARDS: an expanded rationale, justification, and supplementary material. Ferguson N, Fan E, Camporota L, Antonelli M, Anzueto A, Beale R, Brochard L, Brower R, Esteban A, Gattinoni L, Rhodes A, Slutsky AS, Vincent JL, Rubenfeld GD, Thompson BT, Ranieri VM, Intensive Care Med 2012 38 1573 1582 10.1007/s00134-012-2682-1 22926653
4. High-frequency oscillatory ventilation for cardiac surgery children with severe acute respiratory distress syndrome. Li S, Wang X, Yan J, Pediatr Cardiol 2013 34 1382 1388 10.1007/s00246-013-0655-y 23430320
5. Adjunctive therapies in severe pneumonia in critical care patients. Tzovaras N, Karvouniaris M, Makris D, Zakynthinos E, Infect Disord Drug Targets 2011 11 395 400 10.2174/187152611796504863 21679141
6. Clinical characteristics and outcomes of patients with acute lung injury and ARDS. Bhadade RR, de Souza RA, Harde MJ, Khot A, J Postgrad Med 2011 57 286 290 10.4103/0022-3859.90077 22120856
7. Fluid management in acute respiratory distress syndrome. Neamu RF, Martin GS, Curr Opin Crit Care 2013 19 24 30 10.1097/MCC.0b013e32835c285b 23222675
8. Acute respiratory distress syndrome: evaluation and management. Cortes I, Penuelas O, Esteban A, Minerva Anestesiol 2012 78 343 357 22357372
9. Biomarkers in acute lung injury. Bhargava M, Wendt CH, Transl Res 2012 159 205 217 22424425
10. Sepsis impairs alveolar epithelial function by downregulating Na-K-ATPase pump. Berger G, Guetta J, Klorin G, Badarneh R, Braun E, Brod V, Saleh NA, Katz A, Bitterman H, Azzam ZS, Am J Physiol Lung Cell Mol Physiol 2011 301 23 L30 10.1152/ajplung.00010.2010 21478253
11. The acute respiratory distress syndrome. Piantadosi CA, Schwartz DA, Ann Intern Med 2004 141 460 470 10.7326/0003-4819-141-6-200409210-00012 15381520
12. Ubiquitination and proteolysis in acute lung injury. Vadasz I, Weiss CH, Sznajder JI, Chest 2012 141 763 771 10.1378/chest.11-1660 22396561
13. Recent trends in acute lung injury mortality: 1996-2005. Erickson SE, Martin GS, Davis JL, Matthay MA, Eisner MD, Crit Care Med 2009 37 1574 1579 10.1097/CCM.0b013e31819fefdf 19325464
14. Ventilation strategy using low tidal volumes, recruitment maneuvers, and high positive end-expiratory pressure for acute lung injury and acute respiratory distress syndrome: a randomized controlled trial. Meade MO, Cook DJ, Guyatt GH, Slutsky AS, Arabi YM, Cooper DJ, Davies AR, Hand LE, Zhou Q, Thabane L, Austin P, Lapinsky S, Baxter A, Russell J, Skrobik Y, Ronco JJ, Stewart TE, Lung Open Ventilation Study Investigators, JAMA 2008 299 637 645 10.1001/jama.299.6.637 18270352
15. Positive end-expiratory pressure setting in adults with acute lung injury and acute respiratory distress syndrome: a randomized controlled trial. Mercat A, Richard JC, Vielle B, Jaber S, Osman D, Diehl JL, Lefrant JY, Prat G, Richecoeur J, Nieszkowska A, Gervais C, Baudot J, Bouadma L, Brochard L, Expiratory Pressure (Express) Study Group, JAMA 2008 299 646 655 10.1001/jama.299.6.646 18270353
16. Therapeutic effects of human mesenchymal stem cells in ex vivo human lungs injured with live bacteria. Lee JW, Krasnodembskaya A, McKenna DH, Song Y, Abbott J, Matthay MA, Am J Respir Crit Care Med 2013 187 751 760 10.1164/rccm.201206-0990OC 23292883
17. Allogeneic human mesenchymal stem cells for treatment of E. coli endotoxin-induced acute lung injury in the ex vivo perfused human lung. Lee JW, Fang X, Gupta N, Serikov V, Matthay MA, Proc Natl Acad Sci U S A 2009 106 16357 16362 10.1073/pnas.0907996106 19721001
18. Mesenchymal stem cells and inflammatory lung diseases. Iyer SS, Co C, Rojas M, Panminerva Med 2009 51 5 16 19352305
19. Prevention of endotoxin-induced systemic response by bone marrow-derived mesenchymal stem cells in mice. Xu J, Woods CR, Mora AL, Joodi R, Brigham KL, Iyer S, Rojas M, Am J Physiol Lung Cell Mol Physiol 2007 293 131 L141 10.1152/ajplung.00431.2006 17416739
20. Intrapulmonary delivery of bone marrow-derived mesenchymal stem cells improves survival and attenuates endotoxin-induced acute lung injury in mice. Gupta N, Su X, Popov B, Lee JW, Serikov V, Matthay MA, J Immunol 2007 179 1855 1863 10.4049/jimmunol.179.3.1855 17641052
21. Mesenchymal stem cell-based angiopoietin-1 gene therapy for acute lung injury induced by lipopolysaccharide in mice. Xu J, Qu J, Cao L, Sai Y, Chen C, He L, Yu L, J Pathol 2008 214 472 481 18213733
22. Intravenous transplantation of mesenchymal stem cells attenuates oleic acid induced acute lung injury in rats. Xu YL, Liu YL, Wang Q, Li G, Lu XD, Kong B, Chin Med J (Engl) 2012 125 2012 2018 22884070
23. Infusion of freshly isolated autologous bone marrow derived mononuclear cells prevents endotoxin-induced lung injury in an ex-vivo perfused swine model. Rojas M, Parker RE, Thorn N, Corredor C, Iyer SS, Bueno M, Mroz L, Cardenes N, Mora AL, Stecenko AA, Brigham KL, Stem Cell Res Ther 2013 4 26 10.1186/scrt174 23497755
24. Bone marrow-derived mesenchymal stem cells in repair of the injured lung. Rojas M, Xu J, Woods CR, Mora AL, Spears W, Roman J, Brigham KL, Am J Respir Cell Mol Biol 2005 33 145 152 10.1165/rcmb.2004-0330OC 15891110
25. Activation of human mesenchymal stem cells impacts their therapeutic abilities in lung injury by increasing interleukin (IL)-10 and IL-1RN levels. Bustos ML, Huleihel L, Meyer EM, Donnenberg AD, Donnenberg VS, Sciurba JD, Mroz L, McVerry BJ, Ellis BM, Kaminski N, Rojas M, Stem Cells Transl Med 2013 2 884 895 10.5966/sctm.2013-0033 24089414
26. Antioxidant effect of human adult adipose-derived stromal stem cells in alveolar epithelial cells undergoing stretch. Penuelas O, Melo E, Sanchez C, Sanchez I, Quinn K, Ferruelo A, Perez-Vizcaino F, Esteban A, Navajas D, Nin N, Peñuelas O, Melo E, Sánchez C, Sánchez I, Quinn K, Ferruelo A, Pérez-Vizcaíno F, Esteban A, Navajas D, Nin N, Lorente JA, Farré R, Respir Physiol Neurobiol 2013 188 1 8 10.1016/j.resp.2013.04.007 23643709
27. Effect of bone marrow-derived mesenchymal stem cells on endotoxin-induced oxidation of plasma cysteine and glutathione in mice. Iyer SS, Torres-Gonzalez E, Neujahr DC, Kwon M, Brigham KL, Jones DP, Mora AL, Rojas M, Stem Cells Int 2010 2010 868076 21048855
28. Oxidation of extracellular cysteine/cystine redox state in bleomycin-induced lung fibrosis. Iyer SS, Ramirez AM, Ritzenthaler JD, Torres-Gonzalez E, Roser-Page S, Mora AL, Brigham KL, Jones DP, Roman J, Rojas M, Am J Physiol Lung Cell Mol Physiol 2009 296 37 L45 18931052
29. Oxidation of plasma cysteine/cystine redox state in endotoxin-induced lung injury. Iyer SS, Jones DP, Brigham KL, Rojas M, Am J Respir Cell Mol Biol 2009 40 90 98 10.1165/rcmb.2007-0447OC 18664641
30. Cysteine redox potential determines pro-inflammatory IL-1beta levels. Iyer SS, Accardi CJ, Ziegler TR, Blanco RA, Ritzenthaler JD, Rojas M, Roman J, Jones DP, PLoS One 2009 4 5017 10.1371/journal.pone.0005017 19325908
31. Functional expression of beta2 adrenergic receptors responsible for protection against oxidative stress through promotion of glutathione synthesis after Nrf2 upregulation in undifferentiated mesenchymal C3H10T1/2 stem cells. Takahata Y, Takarada T, Iemata M, Yamamoto T, Nakamura Y, Kodama A, Yoneda Y, J Cell Physiol 2009 218 268 275 10.1002/jcp.21594 18814142
32. Mitochondrial transfer between cells can rescue aerobic respiration. Spees JL, Olson SD, Whitney MJ, Prockop DJ, Proc Natl Acad Sci U S A 2006 103 1283 1288 10.1073/pnas.0510511103 16432190
33. Vascular smooth muscle cells initiate proliferation of mesenchymal stem cells by mitochondrial transfer via tunneling nanotubes. Vallabhaneni KC, Haller H, Dumler I, Stem Cells Dev 2012 21 3104 3113 10.1089/scd.2011.0691 22676452
34. Mitochondrial transfer from bone-marrow-derived stromal cells to pulmonary alveoli protects against acute lung injury. Islam MN, Das SR, Emin MT, Wei M, Sun L, Westphalen K, Rowlands DJ, Quadri SK, Bhattacharya S, Bhattacharya J, Nat Med 2012 18 759 765 10.1038/nm.2736 22504485
35. Human mesenchymal stem cells reduce mortality and bacteremia in gram-negative sepsis in mice in part by enhancing the phagocytic activity of blood monocytes. Krasnodembskaya A, Samarani G, Song Y, Zhuo H, Su X, Lee JW, Gupta N, Petrini M, Matthay MA, Am J Physiol Lung Cell Mol Physiol 2012 302 1003 L1013 10.1152/ajplung.00180.2011 22427530
36. Antibacterial effect of human mesenchymal stem cells is mediated in part from secretion of the antimicrobial peptide LL-37. Krasnodembskaya A, Song Y, Fang X, Gupta N, Serikov V, Lee JW, Matthay MA, Stem Cells 2010 28 2229 2238 10.1002/stem.544 20945332
37. The roles of cathelicidin LL-37 in immune defences and novel clinical applications. Nijnik A, Hancock RE, Curr Opin Hematol 2009 16 41 47 10.1097/MOH.0b013e32831ac517 19068548
38. Human but not murine multipotent mesenchymal stromal cells exhibit broad-spectrum antimicrobial effector function mediated by indoleamine 2,3-dioxygenase. Meisel R, Brockers S, Heseler K, Degistirici O, Bülle H, Woite C, Stuhlsatz S, Schwippert W, Jäger M, Sorg R, Henschler R, Seissler J, Dilloo D, Däubener W, Leukemia 2011 25 648 654 10.1038/leu.2010.310 21242993
39. Adventitial delivery of an allogeneic bone marrow-derived adherent stem cell in acute myocardial infarction: phase I clinical study. Penn MS, Ellis S, Gandhi S, Greenbaum A, Hodes Z, Mendelsohn FO, Strasser D, Ting AE, Sherman W, Circ Res 2012 110 304 311 10.1161/CIRCRESAHA.111.253427 22052917
40. Application of MultiStem((R)) allogeneic Cclls for immunomodulatory therapy: clinical progress and pre-clinical challenges in P prophylaxis for graft versus host disease. Vaes B, Van't Hof W, Deans R, Pinxteren J, Front Immunol 2012 3 345 23205020
41. Global characterization and genomic stability of human MultiStem, a multipotent adult progenitor cell. Boozer S, Lehman N, Lakshmipathy U, Love B, Raber A, Maitra A, Deans R, Rao MS, Ting AE, J Stem Cells 2009 4 17 28 20498688
42. Is the intravascular administration of mesenchymal stem cells safe? Mesenchymal stem cells and intravital microscopy. Furlani D, Ugurlucan M, Ong L, Bieback K, Pittermann E, Westien I, Wang W, Yerebakan C, Li W, Gaebel R, Li RK, Vollmar B, Steinhoff G, Ma N, Microvasc Res 2009 77 370 376 10.1016/j.mvr.2009.02.001 19249320
43. Pre-treatment with mesenchymal stem cells reduces ventilator-induced lung injury. Chimenti L, Luque T, Bonsignore MR, Ramirez J, Navajas D, Farre R, Eur Respir J Suppl 2012 40 939 948 10.1183/09031936.00153211
44. Intact epithelial barrier function is critical for the resolution of alveolar edema in humans. Matthay MA, Wiener-Kronish JP, Am Rev Respir Dis 1990 142 1250 1257 10.1164/ajrccm/142.6-Pt-1.1250 2252240
45. Alveolar fluid clearance is impaired in the majority of patients with acute lung injury and the acute respiratory distress syndrome. Ware LB, Matthay MA, Am J Respir Crit Care Med 2001 163 1376 1383 10.1164/ajrccm.163.6.2004035 11371404
46. Bone marrow derived mesenchymal stem cells inhibit inflammation and preserve vascular endothelial integrity in the lungs after hemorrhagic shock. Pati S, Gerber MH, Menge TD, Wataha KA, Zhao Y, Baumgartner JA, Zhao J, Letourneau PA, Huby MP, Baer LA, Salsbury JR, Kozar RA, Wade CE, Walker PA, Dash PK, Cox CS Jr, Doursout MF, Holcomb JB, PLoS One 2011 6 25171 10.1371/journal.pone.0025171 21980392
47. Airway management and smoke inhalation injury in the burn patient. Cancio LC, Clin Plast Surg 2009 36 555 567 10.1016/j.cps.2009.05.013 19793551
48. Therapeutic potential of mesenchymal stem cells for severe acute lung injury. Matthay MA, Thompson BT, Read EJ, McKenna DH Jr, Liu KD, Calfee CS, Lee JW, Chest 2010 138 965 972 10.1378/chest.10-0518 20923800
49. Mesenchymal stem cells for acute lung injury: preclinical evidence. Matthay MA, Goolaerts A, Howard JP, Lee JW, Crit Care Med 2010 38 569 S573 21164399
50. Allogeneic human mesenchymal stem cells restore epithelial protein permeability in cultured human alveolar type II cells by secretion of angiopoietin-1. Fang X, Neyrinck AP, Matthay MA, Lee JW, J Biol Chem 2010 285 26211 26222 10.1074/jbc.M110.119917 20554518
51. Anti-inflammatory effects of mesenchymal stem cells: novel concept for future therapies. Iyer SS, Rojas M, Expert Opin Biol Ther 2008 8 569 581 10.1517/14712598.8.5.569 18407762
52. Mesenchymal stem cell: does it work in an experimental model with acute respiratory distress syndrome? Yilmaz S, Inandiklioglu N, Yildizdas D, Subasi C, Acikalin A, Kuyucu Y, Bayram I, Topak A, Tanyeli A, Duruksu G, Karaoz E, Stem Cell Rev 2013 9 80 92 10.1007/s12015-012-9395-2 22810359
53. Mesenchymal stem cells: a promising therapy for the acute respiratory distress syndrome. Cardenes N, Caceres E, Romagnoli M, Rojas M, Respiration 2013 85 267 278 10.1159/000347072 23428562
54. Intravenous mesenchymal stem cells prevented rejection of allogeneic corneal transplants by aborting the early inflammatory response. Oh JY, Lee RH, Yu JM, Ko JH, Lee HJ, Ko AY, Roddy GW, Prockop DJ, Mol Ther 2012 20 2143 2152 10.1038/mt.2012.165 22929658
55. Human multipotent stromal cells attenuate lipopolysaccharide-induced acute lung injury in mice via secretion of tumor necrosis factor-alpha-induced protein 6. Danchuk S, Ylostalo JH, Hossain F, Sorge R, Ramsey A, Bonvillain RW, Lasky JA, Bunnell BA, Welsh DA, Prockop DJ, Sullivan DE, Stem Cell Res Ther 2011 2 27 10.1186/scrt68 21569482